Skip to content
Screener

Scholar Rock SRRK Long-Term Debt

Long-Term Debt at other companies

Biogen logo
BiogenBIIB
$7.29B+16.0%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$149.38M
Biohaven logo
BiohavenBHVN
$241.91M

Other financials

Income statement

See full
Revenue-
Operating income-$108.9M+2.9%
Net income-$109.9M+0.1%
EPS (diluted)-$0.84+14.3%

Balance sheet

See full
Cash & equivalents$437.1M+186%
Total debt$203.8M+231%
Total equity$253.8M+8.8%
Total assets$523.5M+54.0%

Cash flow

See full
Operating cash flow-$70.3M+8.6%
CapEx$1.0K-99.5%
Free cash flow-$70.3M+8.9%

Valuation

See full
Market cap$6.41B+92.7%
Enterprise value$6.18B+90.9%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-167.8%-4.1pp
Debt / equity0.8×+0.5×
Current ratio+0.7×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The source filing: Scholar Rock’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 7:20 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336732

FAQ

What is Scholar Rock's long-term debt?
Scholar Rock (SRRK) reported long-term debt of $196.2M in Q2 2026.
How has Scholar Rock's long-term debt changed year-over-year?
Scholar Rock's long-term debt increased by 294.3% year-over-year, from $49.76M to $196.2M.
What is the long-term trend for Scholar Rock's long-term debt?
Over 5 years (2020 to 2025), Scholar Rock's long-term debt has grown at a 32.2% compound annual growth rate (CAGR), from $24.68M to $99.71M.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Ask your AI about Scholar Rock's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude